What question did this study set out to answer?

This research aims to characterize outcomes among patients referred with concern for SJS/TEN and compare them to those with confirmed diagnoses.

Outcomes Among Patients Referred with Concern for SJS/TEN: One Burn Center's 10 Year Experience

View Full Paper

Ask AI

Bookmark

Authors

A decade-long review reveals that only a minority of referrals for SJS/TEN are accurately diagnosed, indicating a need for clearer standards.

This research aims to characterize outcomes among patients referred with concern for SJS/TEN and compare them to those with confirmed diagnoses.
Reviewed burn center registry data from 2015-2025 for patients referred with concern for SJS/TEN.
Excluded non-hospitalized patients and those without initial SJS/TEN concerns.
Conducted descriptive statistics on demographics, diagnoses, and mortality rates.
Out of 74 referrals, 22 (29.7%) were diagnosed with SJS/TEN.
Similar demographics and total affected body surface area were observed across both groups.
Most non-SJS/TEN diagnoses included other drug reactions (34.6%), infectious rashes (25%), and dermatitis (15.4%).
Dermatopathology was performed more often for confirming non-SJS/TEN cases (46.2% vs. 22.7%, p=0.06).
Mortality was low and not significantly different in both groups (p=0.83).

Arias-Camison et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

A decade-long review reveals that only a minority of referrals for SJS/TEN are accurately diagnosed, indicating a need for clearer standards.

This research aims to characterize outcomes among patients referred with concern for SJS/TEN and compare them to those with confirmed diagnoses.
Reviewed burn center registry data from 2015-2025 for patients referred with concern for SJS/TEN.
Excluded non-hospitalized patients and those without initial SJS/TEN concerns.
Conducted descriptive statistics on demographics, diagnoses, and mortality rates.
Out of 74 referrals, 22 (29.7%) were diagnosed with SJS/TEN.
Similar demographics and total affected body surface area were observed across both groups.
Most non-SJS/TEN diagnoses included other drug reactions (34.6%), infectious rashes (25%), and dermatitis (15.4%).
Dermatopathology was performed more often for confirming non-SJS/TEN cases (46.2% vs. 22.7%, p=0.06).
Mortality was low and not significantly different in both groups (p=0.83).

Arias-Camison et al. (2026) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark